Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Southern Medical Journal
|
June 1, 1980
Phycomycosis: a cause of bronchial obstruction
J F Donohue, R J Scott, D H Walker, et al.
Pulmonary Circulation
|
January 17, 2017
Tadalafil therapy for sarcoidosis-associated pulmonary hypertension
H J Ford, R P Baughman, R Aris, et al.
Respiratory Medicine
|
July 9, 2013
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
J F Donohue, M R Maleki-Yazdi, S Kilbride, et al.
Urology
|
January 18, 2006
Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate
N J Barber, G Zhu, J F Donohue, et al.
Chest
|
November 18, 2000
The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group
R Casaburi, D D Briggs, J F Donohue, et al.
The American Review of Respiratory Disease
|
May 1, 1989
Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study
N J Gross, T L Petty, M Friedman, et al.
Archives of Internal Medicine
|
May 13, 1996
Characteristics predicting incorrect metered-dose inhaler technique in older subjects
S L Gray, D M Williams, C C Pulliam, et al.
The New England Journal of Medicine
|
July 24, 1980
Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors
P A Aronin, M S Mahaley, S A Rudnick, et al.
Therapeutic Advances in Respiratory Disease
|
January 7, 2009
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance
J F Donohue, N A Hanania, K A Sciarappa, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
November 29, 2011
Ambrisentan for sarcoidosis associated pulmonary hypertension
M A Judson, K B Highland, S Kwon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Southern Medical Journal
|
June 1, 1980
Phycomycosis: a cause of bronchial obstruction
J F Donohue, R J Scott, D H Walker, et al.
Pulmonary Circulation
|
January 17, 2017
Tadalafil therapy for sarcoidosis-associated pulmonary hypertension
H J Ford, R P Baughman, R Aris, et al.
Respiratory Medicine
|
July 9, 2013
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
J F Donohue, M R Maleki-Yazdi, S Kilbride, et al.
Urology
|
January 18, 2006
Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate
N J Barber, G Zhu, J F Donohue, et al.
Chest
|
November 18, 2000
The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group
R Casaburi, D D Briggs, J F Donohue, et al.
The American Review of Respiratory Disease
|
May 1, 1989
Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study
N J Gross, T L Petty, M Friedman, et al.
Archives of Internal Medicine
|
May 13, 1996
Characteristics predicting incorrect metered-dose inhaler technique in older subjects
S L Gray, D M Williams, C C Pulliam, et al.
The New England Journal of Medicine
|
July 24, 1980
Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors
P A Aronin, M S Mahaley, S A Rudnick, et al.
Therapeutic Advances in Respiratory Disease
|
January 7, 2009
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance
J F Donohue, N A Hanania, K A Sciarappa, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
November 29, 2011
Ambrisentan for sarcoidosis associated pulmonary hypertension
M A Judson, K B Highland, S Kwon, et al.
Page
of 3